Linden LLC

Linden to Invest in Aptitude Health

April 26, 2021 | For Immediate Release

Chicago, IL (April 26, 2021) – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today that it will make a majority investment in Aptitude Health Holdings, LLC (“Aptitude Health” or the “Company”) alongside the Company’s founder and management team. Headquartered in Atlanta, GA, Aptitude Health provides market insights and strategic solutions that help translate clinical development into commercial success and life-changing cancer treatments through its proprietary network of over 2,200 community physicians, key opinion leaders, and market access experts.

Alexei Rojanets, CEO and Founder of Aptitude Health, stated “We are proud of the business we have built at Aptitude Health and are excited to partner with Linden to accelerate our growth and expand the breadth of services we can provide to our customers. We chose Linden because of their deep healthcare and pharmaceutical services experience and are confident they have the knowledge and resources to support our shared value creation program.”

Richard Thomas, incoming Chairman of Aptitude Health and industry veteran, said, “We commend Alexei Rojanets, Mike Fleming, and the entire management team at Aptitude Health on building an extraordinary business providing differentiated market insights and strategic solutions to their pharmaceutical clients. The oncology market is complex and challenging, and Aptitude Health is providing valuable insights to help further solve the complex challenges facing oncology drug development and treatment.”

Michael Farah, a Partner at Linden, and incoming board member at Aptitude Health, added “Our investment in Aptitude Health is a result of our dedicated and long-standing pharmaceutical services sector effort, and we are excited to be able to partner with a truly differentiated organization with a strong market reputation. We look forward to partnering with the Aptitude Health team as the Company continues to grow and develop novel ways to provide value to their oncology customers.”

The transaction is expected to close in May of 2021. Kirkland & Ellis LLP is serving as legal advisor to Linden. William Blair & Company is serving as the exclusive financial advisor to Aptitude Health. Twin Brook Capital Partners will be providing debt financing for the transaction.

About Aptitude Health
Aptitude Health is a global healthcare company dedicated to transforming the world’s growing scientific and clinical knowledge into better cancer patient outcomes. Aptitude Health’s evidenced-based solutions assist life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. The Company has a proven track record of providing detailed clinical insights and support to over 55 major life science companies globally. Aptitude Health’s medical expertise is backed by unparalleled access to over 2,200 global disease state experts and community-based oncologists/hematologists.